Cite
HARVARD Citation
Hatic, H. et al. (2022). Time to first treatment is an independent prognostic factor for Multiple Myeloma (MM). Leukemia research. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hatic, H. et al. (2022). Time to first treatment is an independent prognostic factor for Multiple Myeloma (MM). Leukemia research. p. . [Online].